Improving the nerve regeneration ability by inhibiting the orchestral activity of the myelin associated repair inhibitors: an in silico approach
by Sumaira Kanwal; Shazia Perveen
International Journal of Computational Biology and Drug Design (IJCBDD), Vol. 12, No. 3, 2019

Abstract: Nerve injuries plays a significant role in terms of individual's life style as it can be treatable or vice versa in context of the origin of the nerve. Unluckily, the repairing ability of the central nervous system is very restricted because of reduced intrinsic growth capacity, which is much feasible in PNS. These axonal growth inhibitory proteins are mediated via activation of Rho. In the present study, a hybrid approach of comparative modelling and molecular docking followed by inhibitor identification and structure modelling was employed. Our analysis showed that the two important drugs which are widely used have the potential to block the Rho-Rock pathways. Here, we report inhibitors which showed binding affinity for the three most important axonal regeneration inhibitors. Three step approaches can be used to defeat the axonal neuropathies that especially in the CMT disease. However further studies are required to find the applications of these drugs.

Online publication date: Tue, 23-Jul-2019

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Computational Biology and Drug Design (IJCBDD):
Login with your Inderscience username and password:

    Username:        Password:         

Forgotten your password?


Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com